Phase I/II study of multiple-vaccine therapy [cancer vaccines] using epitope peptide restricted to HLA-A [human leukocyte antigen-A] 0201 in treating patients with refractory esophageal cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccine; Cancer vaccines
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 20 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Nov 2009 Biomarkers information updated
- 05 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.